The Use of Not-Negative Conclusions to Describe Results of Formally Negative Trials Presented at Oncology Meetings

This quality improvement analysis of oral presentations of phase 3 randomized clinical trials at recent oncology meetings evaluates the frequency and risks of emphasizing results of borderline significance.

JAMA Oncology